Location
United States, North America
Check Size
$5K - $50K
Investment Stage
Series B
Focus Areas
BioTech
Pharmaceuticals
About Investor
Elliott Sigal is an angel investor based in Carmel, California, specializing in biotechnology and pharmaceuticals. His portfolio includes Mersana Therapeutics and Surface Oncology, both at the Series B stage. He typically invests between $5K and $50K.
Similar Investors
NS
Nikhil Shah
United States, North America
$5K - $50K
Seed
,Series A
,DS
Danielle Strachman
United States, North America
$50K - $400K
Pre Seed
,Seed
,GR
Gokul Rajaram
United States, North America
$25K - $1M
Pre Seed
,Seed
,AB
Amos Ben-Meir
United States, North America
$25K - $200K
Pre Seed
,Seed
,TV
Trae Vassallo
United States, North America
$5K - $50K
Pre Seed
,Seed
,WC
Wayne Chang
United States, North America
$10K - $500K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free